Condition

Amyloid Cardiomyopathy

ClinicalTrials.gov condition label

Clinical trials11

Recruiting3

Common interventions12

Lead sponsors shown7

Clinical trials

11 shown

Cardiac Magnetic Resonance and Echocardiography Study With AcoramidisNCT07695701 · 2026-07-01

RECRUITING

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantNCT06563895 · 2025-05-12

RECRUITING

Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathyNCT06634108 · 2024-09-27

RECRUITING

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)NCT07116473 · 2026-11-01

NOT_YET_RECRUITING

EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)NCT06499064 · 2024-12-01

UNKNOWN

18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL AmyloidosisNCT06048601 · 2023-01-26

UNKNOWN

Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain AmyloidosisNCT05452850 · 2022-08-11

UNKNOWN

Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following ChemotherapyNCT05448716 · 2022-08-10

UNKNOWN

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid CardiomyopathyNCT05795400 · 2022-06-01

COMPLETED

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyNCT03860935 · 2019-03-19

COMPLETED

Monitoring of Early Disease Progression in Hereditary Transthyretin AmyloidosisNCT03431896 · 2018-02-01

COMPLETED

Common interventions

acoramidisDRUG2Placebo Oral TabletDRUG218F-florbetaben PET/CTDIAGNOSTIC_TEST1Acoramidis (AG10)DRUG1Acoramidis (AG10) oral tabletDRUG1Dapagliflozin 10mg TabDRUG1ElectrocardiographyDIAGNOSTIC_TEST1GenisteinDRUG1Left and Right Ventricular Global Strain ImagingDIAGNOSTIC_TEST1Left Atrial Strain ImagingDIAGNOSTIC_TEST1mHealthPROCEDURE1PlaceboDRUG1

Leading sponsors

Eidos Therapeutics, a BridgeBio company4Istanbul University - Cerrahpasa2Fondazione Toscana Gabriele Monasterio1Hospital Universitari de Bellvitge1London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1National Medical Research Center for Cardiology, Ministry of Health of Russian Federation1The Cleveland Clinic1

Trial status mix

UNKNOWN4

COMPLETED3

RECRUITING3

NOT_YET_RECRUITING1

Phase mix

NA3

PHASE33

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.